---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

WuXi AppTec

🌎 wuxiapptec.com

WuXi AppTec is a global company headquartered in Shanghai, providing a comprehensive range of R&D and manufacturing services to the pharmaceutical and biotech industries. With operations across Asia, Europe, and North America, the company supports over 6,000 customers in advancing healthcare products through integrated services that include drug discovery, clinical research, and advanced therapies. WuXi AppTec aims to enable every drug to be made and every disease to be treated, receiving recognition for its commitment to sustainability and innovation.

---

WuXi AppTec - Latest News and Updates

• WuXi AppTec will hold its Q3 2024 earnings call on November 18 with participation from Co-CEOs Dr. Minzhang Chen and Dr. Qing Yang, CFO Ms. Ming Shi, and other executives.
• WuXi AppTec is a key investor in MEGAROBO's recent C-Financing round.
• WuXi AppTec is currently hiring for the position of Associate Director Project Management Oligo and Peptide in the United States.
• WuXi AppTec is hosting an event in Copenhagen with a casual buffet and informative session to discuss the latest industry trends.
• WuXi AppTec will present two posters on NHP and mice models at the SITC Annual Meeting on November 8-9, 2024.

• WuXi AppTec experienced its fourth consecutive quarter of revenue decline amid concerns over the BIOSECURE Act.
• Kyle Thomas has been promoted to Senior Laboratory Technician at WuXi AppTec.
• WuXi AppTec's content team shared insights on how gut microbes regulate stress responsiveness.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.